What if the erratic rhythm of millions of hearts could be decoded not by a stethoscope, but by the raw power of supercomputers? Atrial fibrillation (AF), the most common type of irregular heartbeat, silently threatens lives worldwide, often leading to devastating strokes. This condition,
Imagine a world where millions of people struggle with high cholesterol, a silent threat that fuels heart disease, yet many cannot tolerate standard treatments like statins due to side effects or poor response, leaving them at risk. This pressing challenge affects countless lives, with
Imagine a world where complex cardiac arrhythmias, conditions that disrupt the heart's rhythm and pose significant health risks, can be diagnosed and treated with unprecedented precision and safety. This vision is becoming a reality with the recent U.S. Food and Drug Administration (FDA) clearance
Imagine a world where a cancer diagnosis no longer carries the weight of uncertainty, where treatments are tailored to the unique makeup of each patient, and where technology detects the disease before symptoms even appear. This vision is rapidly becoming reality as oncology undergoes a profound
Glioblastoma, recognized as the most aggressive and deadly form of brain cancer, presents an immense challenge for neurosurgeons tasked with removing tumors that infiltrate healthy brain tissue with devastating precision. The difficulty in achieving complete resection without impairing critical
Antidepressant medications have been a cornerstone of mental health treatment for years, yet for some patients, they come with a significant drawback: unexpected side effects. Recent research led by the University of Tartu Institute of Genomics sheds light on this issue through an in-depth study of
